Altered cell signaling is the molecular basis for cell proliferation occurring in association with several gamma herpesvirus infections. Three gamma herpesviruses, namely EBV/HHV-4, KSHV/HHV-8 and the MHV-68 (and/or MHV-72) and their unusual cell-pirated gene products are discussed in this respect. The EBV, KSHV as well as the MHV DNA may persist lifelong in an episomal form in the host carrier cells (mainly in lymphocytes but also in macrophages, in non-hornifying squamous epithelium and/or in blood vessel endothelial cells). Under conditions of extremely limited transcription, the EBV-infected cells express EBNA1 (EB nuclear antigen 1), the KSHV infected cells express LANA1 (latent nuclear antigen 1), while the MHV DNA carrier cells express the latency-associated protein M2. With the full set of latency-associated proteins expressed, EBV carrier cells synthesize additional EBNAs and at least one LMP (latent membrane protein 1). The latent KSHV carrier cells, in addition to LANA1, may express a viral cyclin, a viral Fas-DD-like ICE inhibitor protein (vFLIP) and a virus-specific transformation protein called kaposin (K12). In MHV latency with a wide expression of latency-associated proteins, the carrier cells express a LANA analogue (ORF73), the M3 protein, the K3/IE (immediate early) proteins and M11/bcl-2 homologue proteins. During the period of limited gene expression, the latency-associated proteins serve mainly for the maintenance of the latent episomal DNA (a typical example is EBNA1). In contrast, during latency with a broader spectrum gene expression, the virus-encoded products activate transcription of otherwise silenced cellular genes, which leads to the synthesis of enzymes capable of promoting not only viral but also cellular DNA replication. Thus, the latency-associated proteins block apoptosis and drive host cells towards division and immortalization. Proliferation of hemopoetic cells, which had become gamma herpesvirus DNA carriers, can be initiated and strongly enhanced in the presence of inflammatory cytokines and by virus-encoded analogues of interleukins, chemokines and IFN regulator proteins. At early stages of tumor formation, many proliferating hemopoetic and/or endothelium cells, which had became transcriptionally active under the influence of chemokines and cytokines, may not yet be infected. In contrast, at later stages of oncogenesis, the virus-encoded proteins, inducing false signaling and activating the proliferation pathways, bring the previously infected cells into full transformation burst.

Institute of Microbiology and Immunology Jessenius Medical Faculty Martin Slovakia

Zobrazit více v PubMed

EMBO J. 1997 Oct 15;16(20):6131-40 PubMed

Am J Pathol. 1994 Oct;145(4):818-26 PubMed

J Gen Virol. 2001 May;82(Pt 5):1187-1197 PubMed

Virology. 1992 Oct;190(2):654-65 PubMed

J Virol. 1992 Aug;66(8):5161-7 PubMed

J Virol. 1993 Jan;67(1):277-87 PubMed

J Virol. 2002 Feb;76(4):1790-801 PubMed

J Virol. 2002 Jan;76(2):802-16 PubMed

J Virol. 1992 Feb;66(2):706-14 PubMed

Annu Rev Immunol. 1997;15:675-705 PubMed

EMBO J. 1996 Feb 1;15(3):457-67 PubMed

J Gen Virol. 1990 Jun;71 ( Pt 6):1365-72 PubMed

Acta Virol. 1994 Jun;38(3):151-6 PubMed

Science. 1998 Aug 28;281(5381):1322-6 PubMed

J Virol. 1997 Sep;71(9):6517-25 PubMed

Science. 1988 Oct 28;242(4878):540-6 PubMed

Rev Med Virol. 2000 Mar-Apr;10(2):83-100 PubMed

Arch Virol. 2000;145(11):2411-20 PubMed

Crit Rev Oncog. 1993;4(2):191-239 PubMed

Int J Cancer. 1968 Nov 15;3(6):857-66 PubMed

Lancet. 1995 Sep 23;346(8978):799-802 PubMed

J Gen Virol. 1996 Apr;77 ( Pt 4):627-30 PubMed

J Biol Chem. 1999 Jul 30;274(31):21569-74 PubMed

J Gen Virol. 1992 Dec;73 ( Pt 12):3275-9 PubMed

Biochim Biophys Acta. 1997 Aug 8;1333(1):M9-17 PubMed

EMBO J. 2000 Jun 15;19(12):3080-9 PubMed

Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2843-7 PubMed

Acta Virol. 2000 Jun-Aug;44(3):211-26 PubMed

Viral Immunol. 2000;13(3):313-27 PubMed

J Virol. 1997 Jan;71(1):715-9 PubMed

J Virol. 1999 Feb;73(2):1023-35 PubMed

Blood. 2000 Feb 15;95(4):1406-12 PubMed

Acta Virol. 1980 Dec;24(6):468 PubMed

Lancet. 1991 Feb 9;337(8737):320-2 PubMed

J Virol. 2001 Feb;75(4):1864-9 PubMed

Blood. 2000 Feb 15;95(4):1151-7 PubMed

Cancer. 1984 Jan 15;53(2):258-66 PubMed

J Infect Dis. 1999 Sep;180(3):824-8 PubMed

Nature. 1997 Apr 3;386(6624):517-21 PubMed

Mol Cell Biol. 1993 Nov;13(11):7045-55 PubMed

Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6343-7 PubMed

Nature. 1999 Dec 23-30;402(6764):889-94 PubMed

Proc Natl Acad Sci U S A. 1982 Dec;79(24):7824-7 PubMed

J Exp Med. 2000 Feb 7;191(3):573-8 PubMed

J Virol. 1997 Aug;71(8):5894-904 PubMed

Mol Pathol. 2000 Oct;53(5):222-37 PubMed

Cancer. 1956 Jul-Aug;9(4):822-30 PubMed

J Virol. 1988 Mar;62(3):902-11 PubMed

Virology. 2002 Feb 1;293(1):54-62 PubMed

J Virol. 2000 Feb;74(4):1593-601 PubMed

Semin Cancer Biol. 2000 Oct;10(5):367-81 PubMed

J Biol Chem. 1997 Aug 1;272(31):19625-31 PubMed

Virology. 1995 May 10;209(1):29-51 PubMed

J Mol Biol. 1995 Jun 9;249(3):520-8 PubMed

EMBO J. 1999 Feb 1;18(3):654-63 PubMed

Int J Cancer. 1988 Aug 15;42(2):213-20 PubMed

Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):499-516 PubMed

J Virol. 1996 Nov;70(11):8218-23 PubMed

J Virol. 1998 Feb;72(2):943-9 PubMed

Acta Virol. 1984 May;28(3):225-31 PubMed

Proc Natl Acad Sci U S A. 1999 May 11;96(10):5704-9 PubMed

J Virol. 2000 Jan;74(1):436-46 PubMed

Curr Opin Immunol. 1998 Jun;10(3):265-70 PubMed

J Virol. 2000 Sep;74(17):8194-201 PubMed

EMBO J. 1999 Feb 1;18(3):644-53 PubMed

Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4546-51 PubMed

J Virol. 1994 Jun;68(6):4067-71 PubMed

Cell. 1985 Oct;42(3):859-68 PubMed

J Virol. 1998 Jul;72(7):5552-8 PubMed

J Virol. 1998 Oct;72(10):8309-15 PubMed

J Exp Med. 1998 Jun 15;187(12):1941-51 PubMed

J Virol. 2001 Feb;75(4):1857-63 PubMed

J Virol. 1992 Jan;66(1):62-9 PubMed

Blood. 1996 Oct 1;88(7):2648-54 PubMed

Virology. 2000 Nov 10;277(1):1-5 PubMed

Int J Cancer. 1976 Dec 15;18(6):798-807 PubMed

J Virol. 1993 Sep;67(9):5303-11 PubMed

Virology. 1992 Mar;187(1):189-201 PubMed

J Virol. 1997 Dec;71(12):9764-9 PubMed

Nature. 1962 Apr 21;194:232-4 PubMed

Science. 1967 Sep 1;157(3792):1064-5 PubMed

Proc Natl Acad Sci U S A. 1983 Aug;80(15):4822-6 PubMed

Viral Immunol. 1999;12(3):237-47 PubMed

J Virol. 2002 Jun;76(12):6244-56 PubMed

Nature. 1992 Mar 26;356(6367):347-50 PubMed

Int J Cancer. 1985 Jan 15;35(1):35-42 PubMed

J Virol. 1994 Jul;68(7):4126-36 PubMed

Virology. 1997 Sep 15;236(1):147-54 PubMed

J Virol. 1990 Oct;64(10):4948-56 PubMed

Histopathology. 1992 Jul;21(1):72-3 PubMed

Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8455-60 PubMed

Mol Cell Biol. 1998 Sep;18(9):5219-28 PubMed

Eur J Cancer. 1991;27(11):1416-23 PubMed

J Gen Virol. 1989 Nov;70 ( Pt 11):2989-3002 PubMed

Nature. 1990 Aug 2;346(6283):470-1 PubMed

Oncogene. 1997 Oct 16;15(16):1979-85 PubMed

J Virol. 2000 Jul;74(14):6324-32 PubMed

Genes Dev. 2000 Jul 1;14(13):1553-77 PubMed

J Virol. 1992 Aug;66(8):5047-58 PubMed

Oncogene. 1988 May;2(5):461-7 PubMed

Lancet. 1972 Nov 11;2(7785):988-9 PubMed

Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9194-9 PubMed

J Virol. 1991 Mar;65(3):1466-78 PubMed

Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7508-13 PubMed

Leuk Lymphoma. 2000 Jul;38(3-4):387-94 PubMed

Nat Med. 1998 Apr;4(4):435-40 PubMed

J Virol. 1996 Oct;70(10):6775-80 PubMed

J Virol. 2000 Jan;74(2):1033-7 PubMed

J Immunol. 1995 Apr 1;154(7):3582-92 PubMed

J Virol. 1989 Feb;63(2):1010-4 PubMed

Cancer Res. 1999 Oct 1;59(19):4984-9 PubMed

Adv Clin Path. 1999 Jan-Apr;3(1-2):11-22 PubMed

Am J Surg Pathol. 1983 Apr;7(3):211-31 PubMed

J Virol. 2001 Apr;75(7):3175-84 PubMed

J Gen Virol. 1999 Dec;80 ( Pt 12):3207-3215 PubMed

Nature. 1984 Jul 19-25;310(5974):207-11 PubMed

Acta Virol. 1982 Jul;26(4):256-63 PubMed

Trends Microbiol. 1997 Oct;5(10):399-405 PubMed

Nat Med. 1997 Mar;3(3):287-92 PubMed

Virology. 1997 Dec 22;239(2):340-51 PubMed

Acta Virol. 1985 Jan;29(1):51-60 PubMed

Virology. 2000 Apr 10;269(2):335-44 PubMed

Microb Pathog. 2001 Aug;31(2):47-58 PubMed

Nature. 1991 Apr 11;350(6318):512-5 PubMed

Br Med J. 1974 May 4;2(5913):253-6 PubMed

Cancer. 1993 Nov 15;72(10):2873-8 PubMed

Am J Pathol. 1992 Apr;140(4):879-87 PubMed

J Virol. 1998 Jun;72(6):4980-8 PubMed

J Gen Virol. 2000 Nov;81(Pt 11):2635-2643 PubMed

IUBMB Life. 2000 Feb;49(2):97-104 PubMed

Nature. 1991 May 2;351(6321):78-80 PubMed

J Virol. 2000 Mar;74(5):2451-4 PubMed

Arch Virol. 2001 Jul;146(7):1415-26 PubMed

Nature. 1997 Jan 23;385(6614):347-50 PubMed

J Virol. 1994 Nov;68(11):7374-85 PubMed

J Virol. 1997 Jan;71(1):839-42 PubMed

Science. 1998 Aug 28;281(5381):1305-8 PubMed

J Virol. 1999 Mar;73(3):2321-32 PubMed

Acta Virol. 1987 Jan;31(1):25-30 PubMed

J Virol. 1990 May;64(5):2369-79 PubMed

Rev Med Virol. 2000 May-Jun;10(3):175-84 PubMed

J Clin Invest. 1997 Nov 15;100(10):2606-10 PubMed

Nature. 1998 Jan 1;391(6662):86-9 PubMed

Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9792-6 PubMed

Mol Cell Biol. 1999 May;19(5):3349-59 PubMed

J Virol. 2001 Apr;75(7):3129-40 PubMed

J Virol. 1999 Dec;73(12):9858-66 PubMed

J Gen Virol. 1998 Dec;79 ( Pt 12):3055-65 PubMed

Nature. 1997 Nov 13;390(6656):184-7 PubMed

J Virol. 1985 Aug;55(2):347-51 PubMed

Adv Cancer Res. 1990;55:133-270 PubMed

Cancer Genet Cytogenet. 1981 Jun;3(4):307-15 PubMed

Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):979-84 PubMed

J Clin Pathol. 1999 Aug;52(8):569-73 PubMed

Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12592-7 PubMed

J Virol. 1999 Apr;73(4):3273-83 PubMed

J Virol. 1999 Sep;73(9):7334-42 PubMed

Cell. 1986 Aug 29;46(5):705-16 PubMed

J Gen Virol. 1992 Sep;73 ( Pt 9):2347-56 PubMed

J Virol. 1999 Jun;73(6):5110-22 PubMed

J Pediatr. 1960 Apr;56:526-35 PubMed

J Virol. 1999 May;73(5):4524-9 PubMed

Nature. 1996 Aug 1;382(6590):410 PubMed

J Gen Virol. 2000 Aug;81(Pt 8):2039-2047 PubMed

Science. 1997 Oct 10;278(5336):290-4 PubMed

Cell. 1989 Aug 11;58(3):527-35 PubMed

Cancer Res. 1981 Nov;41(11 Pt 1):4302-4 PubMed

Nature. 1985 Feb 28-Mar 6;313(6005):812-5 PubMed

Cell. 1995 May 19;81(4):495-504 PubMed

J Antimicrob Chemother. 2000 Apr;45 Suppl T3:15-27 PubMed

Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14862-7 PubMed

J Am Acad Dermatol. 1981 Oct;5(4):468-71 PubMed

Acta Virol. 1998 Apr;42(2):79-82 PubMed

Semin Cancer Biol. 1992 Oct;3(5):285-95 PubMed

Acta Virol. 2002;46(1):19-24 PubMed

Mol Cell Biol. 1989 Mar;9(3):1026-33 PubMed

Science. 1997 Sep 12;277(5332):1656-9 PubMed

J Virol. 2001 Jun;75(11):4955-63 PubMed

First detection of murine herpesvirus 68 in adult Ixodes ricinus ticks